Precision Biologics, Announces Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI)
December 21, 2015 08:00 AM Eastern Standard Time WASHINGTON--(BUSINESS WIRE)-- Today Precision Biologics Inc,...
21Dec
20Aug
Beth Israel Deaconess Medical Center (BIDMC) Joins Precision Biologics as Collaborators on Phase 2B Pancreatic Cancer Trial
Precision Biologics is pleased to announce the addition of Beth Israel Deaconess (BIDMC)as a collaborator...
18Jun
Dana-Farber/Harvard Cancer Center (DF/HCC) and Massachusetts General Hospital (MGH) Join Precision Biologics as Collaborators on Phase 2B Pancreatic Cancer Trial
Precision Biologics is pleased to announce the addition of Dana-Farber/Harvard Cancer Center (DF/HCC) and Massachusetts...
02Jun
Dr. Philip Arlen to Speak at 16th Annual Drug Discovery Summit
Dr. Philip Arlen will be speaking at this years Drug Discovery Summit June 8-9th in...
20May
Precision Biologics Completes Patient Accrual to its Ensituximab Phase 2 Colorectal Cancer Study
FOR IMMEDIATE RELEASE….Rockville, MD, May 20, 2015 Precision Biologics is pleased to announce the completion of...
18May
Yale Cancer Center and the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill Joins Precision Biologics as Collaborators
Precision Biologics is pleased to announce the addition of both Yale Cancer Center at the...
12May
Notice of Annual Meeting of Stockholders To Be Held on June 12, 2015
PRECISION BIOLOGICS, INC. NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 12, 2015 at 6:00...
03Feb
PRNewswire: EMD Millipore Announces Agreement with Precision Biologics, Inc. to Provide Upstream Process Development Services
DARMSTADT, Germany, Feb. 2, 2015 /PRNewswire/ -- EMD Millipore, the Life Science business...
12Jan
NPC-1C Therapy Provides Hope for patients with metastatic Colorectal Cancer Showing Exciting Preliminary Results
Precision Biologics is pleased to announce promising overall survival (OS) data from its ongoing Phase...